778 related articles for article (PubMed ID: 18806702)
1. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
Camilleri M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
[TBL] [Abstract][Full Text] [Related]
2. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
[TBL] [Abstract][Full Text] [Related]
3. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
Quigley EM; Flourie B
Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
[TBL] [Abstract][Full Text] [Related]
4. Review article: probiotics and prebiotics in irritable bowel syndrome.
Spiller R
Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of probiotics in IBS.
Quigley EM
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S85-90. PubMed ID: 18542036
[TBL] [Abstract][Full Text] [Related]
6. Probiotics in functional gastrointestinal disorders: what are the facts?
Quigley EM
Curr Opin Pharmacol; 2008 Dec; 8(6):704-8. PubMed ID: 18775516
[TBL] [Abstract][Full Text] [Related]
7. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
Ringel Y; Ringel-Kulka T
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
[TBL] [Abstract][Full Text] [Related]
8. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
9. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
10. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
Brenner DM; Chey WD
Rev Gastroenterol Disord; 2009; 9(1):7-15. PubMed ID: 19367213
[TBL] [Abstract][Full Text] [Related]
11. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues.
Cuomo R; Savarese MF; Gargano R
Dig Dis; 2007; 25(3):241-4. PubMed ID: 17827948
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for probiotics in irritable bowel syndrome?
Camilleri M
Dig Liver Dis; 2006 Dec; 38 Suppl 2():S266-9. PubMed ID: 17259088
[TBL] [Abstract][Full Text] [Related]
14. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
Quigley EM
J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
Parkes GC; Brostoff J; Whelan K; Sanderson JD
Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
Williams EA; Stimpson J; Wang D; Plummer S; Garaiova I; Barker ME; Corfe BM
Aliment Pharmacol Ther; 2009 Jan; 29(1):97-103. PubMed ID: 18785988
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of probiotics in the treatment of irritable bowel syndrome.
Wilhelm SM; Brubaker CM; Varcak EA; Kale-Pradhan PB
Pharmacotherapy; 2008 Apr; 28(4):496-505. PubMed ID: 18363533
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study.
Andriulli A; Neri M; Loguercio C; Terreni N; Merla A; Cardarella MP; Federico A; Chilovi F; Milandri GL; De Bona M; Cavenati S; Gullini S; Abbiati R; Garbagna N; Cerutti R; Grossi E
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S218-23. PubMed ID: 18685503
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and microflora.
Pimentel M; Chang C
Gastroenterol Clin North Am; 2011 Mar; 40(1):69-85. PubMed ID: 21333901
[TBL] [Abstract][Full Text] [Related]
20. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
Bixquert Jiménez M
Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
